Aclaris Therapeutics Inc. logo

Aclaris Therapeutics Inc. (8AT)

Market Open
5 May, 06:04
1. 25
-0.02
-1.3%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-1.64 Eps
1.27
Previous Close
Day Range
1.25 1.25
Year Range
0.9 4.43
Earnings results expected in 32 days
Want to track 8AT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aclaris Therapeutics Inc. logo
8AT Aclaris Therapeutics Inc.
6 Jun 2025 (32 Days)
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
8AT Aclaris Therapeutics Inc.
25 Feb 2025
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
8AT Aclaris Therapeutics Inc.
4 Nov 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
8AT Aclaris Therapeutics Inc.
7 Aug 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
8AT Aclaris Therapeutics Inc.
5 Aug 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
8AT Aclaris Therapeutics Inc.
6 Jun 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
8AT Aclaris Therapeutics Inc.
27 Feb 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
8AT Aclaris Therapeutics Inc.
23 Feb 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
8AT Aclaris Therapeutics Inc.
22 Feb 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
8AT Aclaris Therapeutics Inc.
21 Feb 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
8AT Aclaris Therapeutics Inc.
6 Nov 2023
-
Cons. EPS
-
EPS